# Children's Hospital Medical Center, Cincinnati: Phase 2 study terminated, 256 enrolled (Allogeneic Stem Cell Transplantation)

**Score:** 75/100

| Field | Value |
|---|---|
| Sponsor | Children's Hospital Medical Center, Cincinnati |
| Sponsor type | Academic and hospital |
| Study | Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant |
| NCT ID | NCT05579639 |
| Phase | Phase 2 |
| Status | terminated |
| Conditions | Allogeneic Stem Cell Transplantation |
| Intervention types | other |
| Target enrollment | 256 |
| Site countries | United States |
| Posted | 2022-10-14 |
| Planned start | 2023-04-04 |
| Event | Terminated |
| Event date | 2026-09-11 |
| Last update posted | 2026-11-02 |

## Why this score
- Posted in the last two weeks.
- Stopped early: budget and sites freed up.
- Phase 2: multi-site, larger budget.
- 256 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT05579639). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.